Physician profile
Fady A Ibrahim
NPI 1861854390
$20,674.19
in general payments reported to CMS, 2019-2025
36 companies · $2,120 in 2025
The $2,120 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $349 · 2021: $1,534 · 2022: $2,546 · 2023: $7,556 · 2024: $6,343 · 2025: $2,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $2,378 · Grant: $1,421 · Consulting Fee: $1,030 · Education: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,845.77 |
| Travel and Lodging | $2,378.14 |
| Grant | $1,420.56 |
| Consulting Fee | $1,030.00 |
| Education | $344.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,611.30 | 2020-2025 | Mitraclip, Navitor, Ensite Precision |
| Shockwave Medical, INC | $2,992.16 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Boston Scientific Corporation | $2,252.54 | 2022-2025 | Watchman Flx, Sentinel, Farapulse |
| Medtronic, INC. | $2,178.93 | 2021-2025 | Turbohawk, Corevalve Evolut R, Onyx Frontier |
| Edwards Lifesciences Corporation | $1,767.20 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $1,576.23 | 2022-2025 | Impella |
| Acist Medical Systems, INC. | $791.36 | 2022-2023 | |
| Chiesi USA, INC. | $591.32 | 2022-2024 | Kengreal, Cleviprex |
| Astrazeneca Pharmaceuticals LP | $496.48 | 2019-2023 | Andexxa, Farxiga |
| Teleflex LLC | $397.39 | 2022-2024 | Turnpike, Manta, Supercross |
| Cardiovascular Systems INC. | $319.48 | 2022-2023 | Diamondback Coronary, Diamondback Peripheral |
| Astellas Pharma US INC | $297.99 | 2019-2021 | |
| Pfizer INC. | $289.06 | 2019-2022 | |
| Philips North America LLC | $275.92 | 2023-2025 | Igt Devices Undivided |
| Janssen Pharmaceuticals, INC | $258.65 | 2021-2024 | Xarelto |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $250.10 | 2021 | |
| Biotronik INC. | $220.19 | 2023 | Orsiro Mission |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $216.01 | 2023 | Lifevest |
| Heartflow, INC. | $213.11 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $189.52 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $186.76 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.06 | 2021-2025 | Jardiance |
| Penumbra, INC. | $160.33 | 2024 | Indigo System |
| Amgen INC. | $138.41 | 2024-2025 | Repatha, Repatha |
| Cathworks, INC. | $125.46 | 2022 | |
| Novo Nordisk INC | $121.83 | 2025 | Wegovy |
| Cordis US Corp. | $118.37 | 2025 | Mynx Control |
| W. L. Gore & Associates, INC. | $101.97 | 2022-2023 | Gore Cardioform Septal Occluder |
| Jenavalve Technology, INC. | $97.62 | 2023 | Jenavalve Pericardial Tavr System |
| Terumo Medical Corporation | $88.20 | 2022-2025 | Glidewire, Navicross, Tr Band |
| Inari Medical, INC. | $68.39 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kestra Medical Technology Services, INC. | $38.53 | 2024 | Assure Wcd |
| Reflow Medical INC | $24.83 | 2024 | |
| Viiv Healthcare Company | $17.81 | 2024 | Cabenuva |
| Irhythm Technologies, INC. | $17.51 | 2024 | Zio Xt Patch, Zio Monitor |
| Lantheus Medical Imaging, INC. | $17.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fady Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.